Tokuda T - Search Results

1

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease.

Majbour NK, Chiasserini D, Vaikath NN, Eusebi P, Tokuda T, van de Berg W, Parnetti L, Calabresi P, El-Agnaf OM. Majbour NK, et al. Among authors: tokuda t. Sci Rep. 2017 Jan 10;7:40263. doi: 10.1038/srep40263. Sci Rep. 2017. PMID: 28071698 Free PMC article.

2

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, Locascio JJ, Schlossmacher MG, El-Agnaf OM. Tokuda T, et al. Biochem Biophys Res Commun. 2006 Oct 13;349(1):162-6. doi: 10.1016/j.bbrc.2006.08.024. Epub 2006 Aug 14. Biochem Biophys Res Commun. 2006. PMID: 16930553

3

An investigation into the lipid-binding properties of alpha-, beta- and gamma-synucleins in human brain and cerebrospinal fluid.

Salem SA, Allsop D, Mann DM, Tokuda T, El-Agnaf OM. Salem SA, et al. Among authors: tokuda t. Brain Res. 2007 Sep 19;1170:103-11. doi: 10.1016/j.brainres.2007.07.027. Epub 2007 Jul 20. Brain Res. 2007. PMID: 17692832

4

Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.

Kasai T, Tokuda T, Yamaguchi N, Watanabe Y, Kametani F, Nakagawa M, Mizuno T. Kasai T, et al. Among authors: tokuda t. Neurosci Lett. 2008 May 2;436(1):52-6. doi: 10.1016/j.neulet.2008.02.057. Epub 2008 Mar 4. Neurosci Lett. 2008. PMID: 18358605

5

CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.

Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, El-Agnaf OM, Yamada M. Noguchi-Shinohara M, et al. Among authors: tokuda t. Brain Res. 2009 Jan 28;1251:1-6. doi: 10.1016/j.brainres.2008.11.055. Epub 2008 Nov 28. Brain Res. 2009. PMID: 19071095

6

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease.

Kasuga K, Tokutake T, Ishikawa A, Uchiyama T, Tokuda T, Onodera O, Nishizawa M, Ikeuchi T. Kasuga K, et al. Among authors: tokuda t. J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):608-10. doi: 10.1136/jnnp.2009.197483. J Neurol Neurosurg Psychiatry. 2010. PMID: 20522869

7

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SA, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, El-Agnaf OM. Tokuda T, et al. Neurology. 2010 Nov 16;75(20):1766-72. doi: 10.1212/WNL.0b013e3181fd613b. Epub 2010 Oct 20. Neurology. 2010. PMID: 20962290 Clinical Trial.

8

[Aiming to develop biochemical biomarkers for Parkinson's disease and related disorders].

Tokuda T. Tokuda T. Rinsho Shinkeigaku. 2012;52(11):1332-4. doi: 10.5692/clinicalneurol.52.1332. Rinsho Shinkeigaku. 2012. PMID: 23196609 Japanese.

9

Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Kasai T, Tokuda T, Ishii R, Ishigami N, Tsuboi Y, Nakagawa M, Mizuno T, El-Agnaf OM. Kasai T, et al. Among authors: tokuda t. J Neurol. 2014 Jun;261(6):1203-9. doi: 10.1007/s00415-014-7334-7. Epub 2014 Apr 16. J Neurol. 2014. PMID: 24737170

10

Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference.

Ishii R, Tokuda T, Tatebe H, Ohmichi T, Kasai T, Nakagawa M, Mizuno T, El-Agnaf OM. Ishii R, et al. Among authors: tokuda t. PLoS One. 2015 Apr 7;10(4):e0123162. doi: 10.1371/journal.pone.0123162. eCollection 2015. PLoS One. 2015. PMID: 25849645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters